Avacta
A website has been launched by Avacta Life Sciences in order to showcase its new affimer technology.
Affimers are a new alternative to antibodies and aptamers. Based on a small protein scaffold, they can be engineered to bind with high specificity and affinity to a wide range of protein targets. Affimers can be used for a wide range of applications in diagnostics, drug/biomarker discovery, biotech research and development and in developing therapeutics.
Avacta’s new website has been responsively designed for optimised viewing on desktop, mobile and tablets.
Michael Vinegrad, head of marketing at Avacta, said: “We’re delighted to now be able to offer our catalogue reagents for sale via a vastly improved, secure ecommerce store. We’re also delighted that the website also functions as a shop window for affimer technology and our seven-week custom Affimer service. The time taken to generate antibodies can be a considerable issue for life scientists. Our seven week service could be a real game changer."